… EVs as drug carriers to develop novel cancer therapeutics. In this review, we have summarized
recent progress in the development of EVs as cancer therapeutics, both in preclinical …

… The past decade has witnessed a rapid growth of research and technology development
related to extracellular vesicles (EVs). Secretion of EVs is a fundamental and evolutionarily …

… Therapeutics are developing EV-based cancer therapeutics, … in precision cancer therapy,
researchers have developed novel … with high loading efficiency, tumor-targeting ability, and …

… , modulation of extracellular matrix (ECM), as … cancer treatment by promoting drug resistance
and cancer survival through activation of oncogenic pathways. In human epidermal growth …

… of cancer-derived EVs by targeting HER-2 could be highly beneficial for cancer treatment. In
… potential of eliminating circulating EVs for cancer treatment. We showed the effectiveness of …

… because it is difficult to distinguish the different types of vesicles after their … “extracellular
vesicles (EVs)” as a hypernym for all types of vesicles that are present in the extracellular space […

… that can operate over both short and long distances has recently emerged, based on the
release and uptake of membrane-bound vesicles termed extracellular vesicles (EVs) [ …

… drugs through neutralization of those antitumor drugs that are weak bases or isolating drugs
in acidic vesicles and… Extracellular vesicles may also promote tumor progression through the …

… anticancer therapeutics, engineering strategies for cancer therapy have been widely explored
in the last decade, along with other cancer therapies. However, therapeutic applications of …

… extracellular vesicles to metastasis. This review will focus on the role of extracellular vesicles
in cancer … as their potential role as biomarkers in tumor diagnosis and prognosis. This will …